Latest news
Sobi pens $580M deal for Innate’s cancer drug before ph. 3 push - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 11:13:48 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron'sBarron's · Fri, 07 Aug 2026 19:33:00 GMTBiotech Stocks: The New Drugs That Could Fuel Big Gains - Barron'sBarron's · Fri, 07 Aug 2026 15:30:00 GMTBlocked artery, failed liver cancer treatment: How doctors used a rare three-hour procedure to reach the - The Times of IndiaThe Times of India · Fri, 07 Aug 2026 14:30:00 GMTUndercover reporter offered fenbendazole and ivermectin as cancer treatment - BBCBBC · Wed, 05 Aug 2026 05:07:27 GMT